PSME1 and breast carcinoma: Similar to the outcomes of PA28α/β-silencing, loss of β5i also greatly inhibited the invasive and migratory ability of breast cancer cells (Figure 3C and Figure S3B), however, β5i-silencing did not slow down the proliferation rate (Figure S3C).